Publicaciones (2012-2017)

• E. Fuente-Martín , C. García-Cáceres , M. Granado , M L. de Ceballos , M.A. Sánchez-Garrido, B. Sarman , Z.-W. Liu , M. O. Dietrich, M. Tena-Sempere , P. Argente-Arizón , F. Díaz , J. Argente, T. L. Horvath , J. A. Chowen. Leptin regulates glutamate transporters in hypothalamic astrocytes. J.Clin.Invest. 122 (2012): 3900-13. Free PMC article

• A.M. Martín-Moreno, B. Brera, C. Spuch, E. Carro, L. García-García, M. Delgado, M.A. Pozo, N. Innamorato, A. Cuadrado, M. L. de Ceballos. Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers β-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice. J.Neuroinflamm. (2012) 9 (1):8. Free PMC article

• C. Lemos, A. Valério-Fernandes, G. C. Ghisleni, S. G. Ferreira, C. Ledent, M. L. de Ceballos, A. Köfalvi. Impaired hippocampal glucoregulation in the cannabinoid CB1 receptor knockout mice as revealed by an optimized in vitro experimental approach. J Neurosci Methods 204 (2012) 366– 373

• Pérez-González R, Alvira-Botero MX, Robayo O, Antequera D, Garzón M, Martín-Moreno AM, Brera B, de Ceballos ML, Carro E. Leptin gene therapy attenuates neuronal damages evoked by amyloid-β and rescues memory deficits in APP/PS1 mice. Gene Ther. 21 (2014) 298-308

• Pascual AC, Martín-Moreno AM, Giusto NM, de Ceballos ML, Pasquaré SJ. Normal ageing in the rat and pathological ageing in human Alzheimer’s disease decreases FAAH activity: Modulation by cannabinoid agonists. Exp.Geront. 60 (2014) 92-99

• Nieto E, Delgado M, Sobrado M, de Ceballos ML, Alajarín R, García-García L, Kelly J, Lizasoain I, Pozo MA , Álvarez-Builla J. Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[18F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke. Eur.J.Med.Chem. 101 (2015) 604-615

• E. Fuente-Martín, C. García-Cáceres, P. Argente-Arizón, F. Díaz, M. Granado, D.Castro-González, M. L. de Ceballos, S. L. Dickson, J.Argente, J. A. Chowen. Ghrelin Regulates Glucose and Glutamate Transporters in Hypothalamic Astrocytes. Scient. Rep. (2016) 6:23673

• A. Köfalvi, C. Lemos, A. M. Martín-Moreno, B. S. Pinheiro, L. García-García, M. A. Pozo, Â. Valério-Fernandes, R. O. Beleza, P. Agostinho, R. J. Rodrigues, S. J. Pasquaré, R. A. Cunha, M. L. de Ceballos. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease. Neuropharmacology (2016pii: S0028-3908(16)30087-9. doi: 10.1016/j.neuropharm.2016.03.015. [Epub ahead of print]

• Pajares M, Jiménez-Moreno N, García-Yagüe ÁJ, Escoll M, de Ceballos ML, Van Leuven F, Rábano A, Yamamoto M, Rojo AI, Cuadrado A. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016 Jul 18:0. [Epub ahead of print]

• J.- J. Navarro-Dorado, N. Villalba, D. Prieto, B. Brera, A. M. Martín-Moreno, T. Tejerina, M. L. de Ceballos. Vascular dysfunction in a transgenic model of Alzheimer’s disease: Effects of CB1R and CB2R cannabinoid agonists. Frontiers in Neuroscience (2016) 16 September 2016 | http://dx.doi.org/10.3389/fnins.2016.00422

• P.Pérez-Domper, V. Palomo, S. Gradari, C. Gil, M. L de Ceballos, A. Martínez, J.L. Trejo. The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis. Neuropharmacology 116 (2017) 174-187

• S.Ballesteros, J. Mayas, E. Ruíz, A. Prieto, P. Toril, L. Ponce de León, M. L. de Ceballos, J. M. Reales. Effects of video game training on behavioral and electrophysiological measures of attention and memory: Protocol for a randomized controlled trial. JMIR Res.Protocols (2017) 6(1):e8. doi: 10.2196/resprot.6570

Libros, monografías y volúmenes colectivos:

• A.Alsasua, E.Blanco, P.D’Ocón, C.C.Faura, M.C. Iglesias-Osma, M.L.de Ceballos, M.T.Tejerina. Aportaciones de los medicamentos a la salud y calidad de vida de los pacientes (II). Actualidad en Farmacología y Terapéutica 9 (2012) 198-209. R

• M.L.de Ceballos. Cannabinoids for the treatment of Neuroinflammation. In: Cannabinoids in Neurological and Mental diseases. (L.Fattore, ed.), Amsterdam, Holanda: Elsevier pp 3-14 (2015). CL.

• M.L.de Ceballos, Köfalvi A. Boosting brain glucose metabolism to fight neurodegeneration? Oncotarget. 2017 Feb 6. doi: 10.18632/oncotarget.15131. [Epub ahead of print]. Editorial.